Medidata and Techfields Launch mHealth Stroke Study

Article

MediData announced that Techfields Pharma has selected its Clinical Cloud solution to power a Phase II schemic stroke study.

Medidata announced that Techfields Pharma has selected its Clinical Cloud solution to power a Phase II schemic stroke study. The China-based company plans to use Medidata’s solution and mHealth technology to improve trial processes and gather new insights.

Read the full release here

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.